Breast
Node Positive (1-3 nodes), HR pos, HER2-neg
- SWOG S1007: Rx PONDER Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Node Positive or High Risk Node Negative, HER2-Neg
-
CTSU B-49: Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Stage III (locally advanced), Metastatic, or Recurrent Disease
- CTSU E3108: A Phase II Prospective Trial Correlating Progression Free Survival with CYP2D6 Activity in Patients with Metastatic Breast Cancer Treated with Single Agent Tamoxifen
Stage IV
- CTSU E2108: Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
For more information, contact Cheryl Patz, RN, OCN, CCRC, at (360) 715-4133.
